Abatacept Shortage

This information was kindly shared with us by Arthritis Australia. It is current as of 16 May 2024.


Bristol Myers Squibb (BMS), the manufacturer of abatacept (Orencia®), has announced a shortage of both the ClickJect (autoinjector) and pre-filled syringe subcutaneous formulations of the medication.

The unavailability of abatacept has commenced earlier than anticipated for a period expected to be several months. BMS have advised that this is due to manufacturing delays and increased demand, and that Australia is not the only country affected.

In response to the shortage, Arthritis Australia is working with BMS, the Australian Rheumatology Association (ARA) and the Therapeutic Goods Administration (TGA) to manage supply.

Unfortunately, most patients currently using subcutaneous abatacept will need to switch to an alternative biological or targeted synthetic disease-modifying antirheumatic drug (b/tsDMARD) as soon as possible.

If your treating rheumatologist or clinical immunologist has not yet been in touch with you, we recommend that you contact them as soon as possible.

Recommendations for People Who Need to Remain on Abatacept

BMS has put in place an Orencia® Stock Hypercare Plan (OSHP) to manage orders of abatacept (Orencia®) and dispensing from pharmacies throughout the shortage.

If you have been told by your specialist (rheumatologist or clinical immunologist) that you should remain on abatacept, you will need to receive a completed OSHP Eligibility Form from your specialist and present it to your pharmacy (the form can also be emailed directly to the pharmacy by your specialist).

You may need to switch between the Orencia prefilled syringe and the ClickJect (autoinjector) during the shortage if only one of these products is available.

  • Both products contain the same medicine (abatacept), at the same strength (125 mg/mL), and are given by subcutaneous injection, but the injection device is different.
  • If your pharmacist offers you a substitute medicine, they should explain the differences between the prefilled syringe and the ClickJect (autoinjector) and how to give the product you have been switched to.
  • At your next appointment with your specialist, ask them to show you how to use both products in case you need to switch temporarily.
  • Talk to your specialist or pharmacist if you have any questions about this substitution.

Recommendations for Rheumatologists

The Australian Rheumatology Association (ARA) has issued recommendations to rheumatologists to manage the shortage effectively:

  • No new patients should be started on subcutaneous or intravenous abatacept.
  • Patients should be switched to an alternative biological or targeted synthetic disease-modifying anti-rheumatic drug (b/tsDMARD) where possible.
  • Stock should be conserved for patients who have previously used two other b/tsDMARDs, or who have a relative or absolute contraindication to other b/tsDMARDs.

As details unfold, Arthritis Australia will be actively working with Bristol Myers Squibb (BMS), the Therapeutic Goods Administration (TGA), the Australian Rheumatology Association (ARA) and pharmacists to minimise any disruptions to consumers. CreakyJoints Australia will share new information as it comes to hand.

Join the CreakyJoints Australia

Becoming a CreakyJoints Australia member takes just a few minutes. You’ll receive our members’ e-newsletter featuring:

  • Reliable information about arthritis types and treatments.
  • Tips for managing daily life with arthritis and related conditions.
  • Personal stories from people living with similar conditions to you.
  • Links to our podcasts featuring interviews with health clinicians and patients.
  • Surveys to help us discover what’s important to you.

Click here to register

Follow Us on Social Media

We set up our CreakyJoints Australia Community group on Facebook to share our latest news, feature articles, arthritis resources and other content with you. We invite you to provide feedback on any of our posts and chat with each other in the comments. You are also welcome to share ideas about content you would like us to create or share practical tips for living with arthritis and related conditions.

You can also follow CreakyJoints Australia on Twitter/X and Instagram.

Keep Reading